• Coulter Center for Translational Research

    All too often, innovations in biomedical engineering that could significantly improve the healthcare of people around the world never enter the marketplace. The University of Virginia has joined forces with the Wallace H. Coulter Foundation in a groundbreaking effort to address the root causes of this bottleneck and commercialize promising treatments and techniques.
    Capabilities
    • Early stage funding
    • Translational research management
  • Global Infectious Diseases Institute

    The Institute aims to address three major 21st-century concerns: diarrheal disease in children, pandemic threats and the most resistant and urgent infectious organisms known as superbugs. The institute takes an interdisciplinary approach, from the identification and diagnosis of disease to intervention to evaluation, in order to understand the mechanisms of disease and intervene medically, socially and through policy. UVA Engineering Representatives: Roseanne M. Ford and Jason Papin.
  • Hossack Lab

    Hossack Lab is a group of researchers who study ultrasound and ultrasound contrast agents to advance innovative applications in disease diagnosis, treatment, and monitoring.